Business Context and Reporting Period
This Form 8-K Current Report, dated June 22, 2026, details material agreements and equity transactions for VisionWave Holdings, Inc. (VWAV). The filing reports the consummation of Stage 2 and Stage 3 closings under an Exchange Agreement with SaverOne 2014 Ltd. and the execution of an Assignment Agreement with Adrian Holdings S.R.L. to partially satisfy a promissory note.
Key Financial Metrics and Transactions
- Equity Issuance: The Company issued an aggregate of 1,331,637 shares of common stock to SaverOne as consideration for the Stage 2 and Stage 3 closings.
- Transaction Value: The issued shares had an aggregate value of approximately $4,256,863 ($2,743,137 for Stage 2 and $1,513,726 for Stage 3), based on the VWAV Average Price.
- Debt Reduction: The outstanding principal of a $10,000,000 promissory note (the "Adrian Note") issued to Adrian Holdings S.R.L. was reduced by approximately $1.43 million.
- Ownership Stake: Following the transactions, VisionWave beneficially owns approximately 41% of SaverOne's issued and outstanding ordinary shares.
- Accounting Treatment: The Company does not control SaverOne and will not consolidate its financial statements; the investment will be accounted for under the equity method.
Material Changes and Agreements
Assignment of Exchange Rights: VisionWave assigned its right to receive 14,843,945,442 SaverOne ordinary shares (the "Assigned Shares") to Adrian Holdings S.R.L. These shares were issued directly to Adrian, bypassing VisionWave, which acted solely as a conduit.
Note Satisfaction Mechanism: The reduction of the Adrian Note was calculated at 110% of the value of the Assigned Shares. This transaction reduced the debt obligation without altering the total number of SaverOne shares issuable or the consideration payable to SaverOne under the original Exchange Agreement.
Unregistered Sales: The issuance of VisionWave shares to SaverOne was conducted in reliance on exemptions under Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D, as the transaction involved an accredited investor and no public offering.
Outlook, Risks, and Management Commentary
Forward-Looking Statements: The filing contains statements regarding future business plans, the integration of technologies, and the expectation that the investment in SaverOne will be accounted for under the equity method. Management notes that actual results may differ materially from these expectations.
Risks and Contingencies: The filing references risks described in the Company's most recent Form 10-K and Form 10-Q. A specific contingency noted is that $100,000 worth of shares (based on a $5.34 VWAP) was set aside and not delivered pending SaverOne providing management names for allocation.
Guidance: The filing does not provide specific financial guidance, revenue forecasts, or updated earnings projections beyond the completion of the described milestones.
Investor Verification Checklist
- Verify the current trading price of VWAV to assess the dilution impact of the 1,331,637 shares issued.
- Confirm the remaining principal balance of the Adrian Note after the $1.43 million reduction.
- Review the full text of the Assignment Agreement (Exhibit 10.1) for specific adjustment mechanisms regarding the Note Reduction Amount.
- Monitor the status of the $100,000 share allocation pending SaverOne management identification.
- Assess the implications of the 41% ownership stake and equity method accounting on future financial reporting.